VEEVA SYS INC's ticker is VEEV and the CUSIP is 922475108. A total of 156 filers reported holding VEEVA SYS INC in Q4 2014. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
About VEEVA SYS INC
Veeva Systems Inc. is a cloud-based software company that provides solutions for the life sciences industry. The company's software is used by pharmaceutical and biotech companies to manage their sales, marketing, and clinical operations. Veeva's software is designed to help these companies improve their efficiency, compliance, and customer engagement.
Veeva's software suite includes products for customer relationship management, content management, data management, and clinical operations. The company's products are built on a single cloud platform, which allows for seamless integration and data sharing across different departments and functions.
Veeva has been growing rapidly in recent years, with revenue increasing by over 25% in the last fiscal year. The company has a strong customer base, with over 900 customers worldwide, including many of the world's largest pharmaceutical companies.
One of the key factors driving Veeva's success is its focus on the life sciences industry. By specializing in this industry, Veeva has been able to develop software that meets the unique needs and regulatory requirements of pharmaceutical and biotech companies. This has helped the company to differentiate itself from other cloud software providers and build a strong reputation in the industry.
Overall, Veeva Systems Inc. is a promising company with a strong track record of growth and a solid customer base. As the life sciences industry continues to evolve and become more reliant on technology, Veeva is well-positioned to continue its success and help its customers navigate the changing landscape.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $4,412,000 | +1082.8% | 60,427 | +795.1% | 0.36% | +2320.0% |
Q4 2017 | $373,000 | -95.3% | 6,751 | -95.3% | 0.02% | -98.0% |
Q3 2017 | $8,020,000 | +305.3% | 142,181 | +340.5% | 0.76% | +323.9% |
Q2 2017 | $1,979,000 | +816.2% | 32,276 | +667.0% | 0.18% | +650.0% |
Q1 2017 | $216,000 | -96.9% | 4,208 | -97.5% | 0.02% | -96.8% |
Q3 2016 | $6,963,000 | +324.6% | 168,686 | +251.0% | 0.76% | +267.6% |
Q2 2016 | $1,640,000 | +283.2% | 48,065 | +196.7% | 0.21% | +15.6% |
Q4 2014 | $428,000 | – | 16,198 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mitra Capital LLC | 55,000 | $2,820,000 | 5.27% |
Brown Capital Management | 7,423,513 | $380,678,000 | 5.08% |
White Elm Capital, LLC | 349,400 | $17,917,000 | 3.34% |
GLYNN CAPITAL MANAGEMENT LLC | 197,424 | $10,124,000 | 3.06% |
EMERALD ADVISERS, LLC | 1,316,040 | $67,487,000 | 2.77% |
Tygh Capital Management, Inc. | 216,622 | $11,108,000 | 2.60% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,024,938 | $52,559,000 | 2.40% |
Dorsal Capital Management, LP | 850,000 | $43,588,000 | 2.32% |
RIVERBRIDGE PARTNERS LLC | 2,058,387 | $105,554,000 | 2.12% |
Avalon Global Asset Management LLC | 75,000 | $3,846,000 | 2.01% |